Insilico Medicine, a China-based artificial intelligence-driven drug discovery company, has closed the second tranche of its Series D round on USD 35m, with Prosperity7 Ventures taking the lead.
The overall total now stands at USD 95m, following a first tranche of USD 60m in June featuring an unnamed US asset manager and BHR Partners, with re-ups from the likes of Warburg Pincus, B Capital Group,...
Japanese healthcare technology start-up Ubie has closed its Series C round on JPY6.3bn (USD 43.2m) with the latest tranche featuring PE-owned pharmacy chain operator Sogo Medical.
Specialist food and agriculture investor Proterra Investment Partners has agreed to invest in Aperion Bioenergy, a Singapore-based bioenergy producer that sources used cooking oil for feedstocks.
Dymon Asia Private Equity (DAPE) has closed its third Southeast Asia middle market private equity fund at a hard cap of USD 650m, beating a target of USD 550m.
Gamurs, a Sydney-headquartered media company specialising in gaming, e-sports, and entertainment, has secured USD 12m in Series A funding.